Literature DB >> 32717224

Inhibition, crystal structures, and in-solution oligomeric structure of aldehyde dehydrogenase 9A1.

Jesse W Wyatt1, David A Korasick2, Insaf A Qureshi3, Ashley C Campbell2, Kent S Gates4, John J Tanner5.   

Abstract

Aldehyde dehydrogenase 9A1 (ALDH9A1) is a human enzyme that catalyzes the NAD+-dependent oxidation of the carnitine precursor 4-trimethylaminobutyraldehyde to 4-N-trimethylaminobutyrate. Here we show that the broad-spectrum ALDH inhibitor diethylaminobenzaldehyde (DEAB) reversibly inhibits ALDH9A1 in a time-dependent manner. Possible mechanisms of inhibition include covalent reversible inactivation involving the thiohemiacetal intermediate and slow, tight-binding inhibition. Two crystal structures of ALDH9A1 are reported, including the first of the enzyme complexed with NAD+. One of the structures reveals the active conformation of the enzyme, in which the Rossmann dinucleotide-binding domain is fully ordered and the inter-domain linker adopts the canonical β-hairpin observed in other ALDH structures. The oligomeric structure of ALDH9A1 was investigated using analytical ultracentrifugation, small-angle X-ray scattering, and negative stain electron microscopy. These data show that ALDH9A1 forms the classic ALDH superfamily dimer-of-dimers tetramer in solution. Our results suggest that the presence of an aldehyde substrate and NAD+ promotes isomerization of the enzyme into the active conformation.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ALDH9A1; Aldehyde dehydrogenase; Analytical ultracentrifugation; Covalent reversible inhibitor; DEAB; Diethylaminobenzaldehyde; Negative-stain electron microscopy; Small-angle X-ray scattering; Time-dependent inhibition; X-ray crystallography

Mesh:

Substances:

Year:  2020        PMID: 32717224      PMCID: PMC7484307          DOI: 10.1016/j.abb.2020.108477

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  62 in total

1.  UCSF Chimera--a visualization system for exploratory research and analysis.

Authors:  Eric F Pettersen; Thomas D Goddard; Conrad C Huang; Gregory S Couch; Daniel M Greenblatt; Elaine C Meng; Thomas E Ferrin
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

2.  Molecular and biochemical characterization of rat gamma-trimethylaminobutyraldehyde dehydrogenase and evidence for the involvement of human aldehyde dehydrogenase 9 in carnitine biosynthesis.

Authors:  F M Vaz; S W Fouchier; R Ofman; M Sommer; R J Wanders
Journal:  J Biol Chem       Date:  2000-03-10       Impact factor: 5.157

3.  Improving the success rate of protein crystallization by random microseed matrix screening.

Authors:  Marisa Till; Alice Robson; Matthew J Byrne; Asha V Nair; Stefan A Kolek; Patrick D Shaw Stewart; Paul R Race
Journal:  J Vis Exp       Date:  2013-08-31       Impact factor: 1.355

4.  Sheep liver cytosolic aldehyde dehydrogenase: the structure reveals the basis for the retinal specificity of class 1 aldehyde dehydrogenases.

Authors:  S A Moore; H M Baker; T J Blythe; K E Kitson; T M Kitson; E N Baker
Journal:  Structure       Date:  1998-12-15       Impact factor: 5.006

5.  Structure of betaine aldehyde dehydrogenase at 2.1 A resolution.

Authors:  K Johansson; M El-Ahmad; S Ramaswamy; L Hjelmqvist; H Jörnvall; H Eklund
Journal:  Protein Sci       Date:  1998-10       Impact factor: 6.725

6.  Slow-tight binding inhibition of xylanase by an aspartic protease inhibitor: kinetic parameters and conformational changes that determine the affinity and selectivity of the bifunctional nature of the inhibitor.

Authors:  Chandravanu Dash; Vinod Vathipadiekal; Sudeep P George; Mala Rao
Journal:  J Biol Chem       Date:  2002-02-13       Impact factor: 5.157

7.  Structural and Biochemical Characterization of Aldehyde Dehydrogenase 12, the Last Enzyme of Proline Catabolism in Plants.

Authors:  David A Korasick; Radka Končitíková; Martina Kopečná; Eva Hájková; Armelle Vigouroux; Solange Moréra; Donald F Becker; Marek Šebela; John J Tanner; David Kopečný
Journal:  J Mol Biol       Date:  2018-12-21       Impact factor: 5.469

8.  The structure of retinal dehydrogenase type II at 2.7 A resolution: implications for retinal specificity.

Authors:  A L Lamb; M E Newcomer
Journal:  Biochemistry       Date:  1999-05-11       Impact factor: 3.162

9.  Preclinical profile of VX-950, a potent, selective, and orally bioavailable inhibitor of hepatitis C virus NS3-4A serine protease.

Authors:  Robert B Perni; Susan J Almquist; Randal A Byrn; Gurudatt Chandorkar; Pravin R Chaturvedi; Lawrence F Courtney; Caroline J Decker; Kirk Dinehart; Cynthia A Gates; Scott L Harbeson; Angela Heiser; Gururaj Kalkeri; Elaine Kolaczkowski; Kai Lin; Yu-Ping Luong; B Govinda Rao; William P Taylor; John A Thomson; Roger D Tung; Yunyi Wei; Ann D Kwong; Chao Lin
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

10.  Identification of cancer-type specific expression patterns for active aldehyde dehydrogenase (ALDH) isoforms in ALDEFLUOR assay.

Authors:  Lei Zhou; Dandan Sheng; Dong Wang; Wei Ma; Qiaodan Deng; Lu Deng; Suling Liu
Journal:  Cell Biol Toxicol       Date:  2018-09-15       Impact factor: 6.691

View more
  6 in total

Review 1.  Impact of missense mutations in the ALDH7A1 gene on enzyme structure and catalytic function.

Authors:  David A Korasick; John J Tanner
Journal:  Biochimie       Date:  2020-09-19       Impact factor: 4.079

2.  Structure of putative tumor suppressor ALDH1L1.

Authors:  Yaroslav Tsybovsky; Valentin Sereda; Marcin Golczak; Natalia I Krupenko; Sergey A Krupenko
Journal:  Commun Biol       Date:  2022-01-10

Review 3.  Aldehyde Dehydrogenase 2 as a Therapeutic Target in Oxidative Stress-Related Diseases: Post-Translational Modifications Deserve More Attention.

Authors:  Jie Gao; Yue Hao; Xiangshu Piao; Xianhong Gu
Journal:  Int J Mol Sci       Date:  2022-02-28       Impact factor: 5.923

Review 4.  Formation and repair of unavoidable, endogenous interstrand cross-links in cellular DNA.

Authors:  Kurt Housh; Jay S Jha; Tuhin Haldar; Saosan Binth Md Amin; Tanhaul Islam; Amanda Wallace; Anuoluwapo Gomina; Xu Guo; Christopher Nel; Jesse W Wyatt; Kent S Gates
Journal:  DNA Repair (Amst)       Date:  2020-12-24

5.  Identification of Novel Therapeutic Targets for Polyglutamine Diseases That Target Mitochondrial Fragmentation.

Authors:  Annika Traa; Emily Machiela; Paige D Rudich; Sonja K Soo; Megan M Senchuk; Jeremy M Van Raamsdonk
Journal:  Int J Mol Sci       Date:  2021-12-14       Impact factor: 5.923

6.  Study of ALDH from Thermus thermophilus-Expression, Purification and Characterisation of the Non-Substrate Specific, Thermophilic Enzyme Displaying Both Dehydrogenase and Esterase Activity.

Authors:  Kim Shortall; Edel Durack; Edmond Magner; Tewfik Soulimane
Journal:  Cells       Date:  2021-12-14       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.